Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

GRIN2A Gene Epilepsy with Neurodevelopmental Defects Genetic Test in UAE | 2800 AED | DHA Approved

Executive Summary & Core Metrics

Core Metrics

  • Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 certified NGS processing.
  • Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
  • Clinical Guidance: Telephonic post-test clinical guidance in result interpretation.
  • Insurance Support: Direct billing verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The GRIN2A gene encodes a critical NMDA receptor subunit; pathogenic variants are associated with epilepsy-aphasia syndromes and neurodevelopmental defects. Our Next-Generation Sequencing (NGS) test delivers full gene coverage with high analytical sensitivity, enabling precise molecular diagnosis and personalised therapeutic guidance.

Feature Our Test (ISO-Certified NGS) Closest Alternative (Standard Sanger Sequencing)
Precision 99.9% analytical sensitivity; detects SNVs, indels, CNVs 99.0% for targeted regions; limited to point mutations
Methodology NGS with ACMG-guided variant interpretation, ISO 9001:2015 lab Sanger sequencing, single-gene; no CNV detection
Turnaround Time 3 to 4 weeks 6 to 8 weeks
Clinical Report Comprehensive, with therapeutic implications and genetic counselling Basic variant listing, minimal interpretive support

Physician Insight & Safety Protocols

“As a Consultant Medical Genetics, I emphasise that genetic results are a piece of a complex puzzle; they must be correlated with clinical history and family findings. Never alter medication without professional guidance, as abrupt changes can trigger severe seizures or developmental regression. I stand by every report we provide, ensuring it leads to safer, more informed care.” – Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403

Medication Advisory

Do not discontinue or adjust prescribed antiepileptic drugs or neurological medications without consulting your physician.

Safety Exclusion Criteria & Emergency Indicators

  • Exclusion Criteria: Active febrile illness or acute seizure exacerbation at time of blood draw (reschedule after stabilisation); inability to provide informed consent (for minors, guardian consent mandatory per Federal Decree-Law No. 4 of 2016 on Medical Liability).
  • Emergency Red Flags: Seizure clusters lasting >5 minutes, loss of consciousness, new-onset status epilepticus, or sudden neurodevelopmental regression—seek immediate emergency care.
  • Pregnancy/Lactation: Not applicable for DNA testing; however, if sedation is required for sample collection, inform the provider.

Patient FAQ & Clinical Guidance

1. How can this genetic test explain my child’s epilepsy and developmental delay?

Answer: This sequences the GRIN2A gene, which when mutated has been directly linked to epilepsy-aphasia syndromes and neurodevelopmental defects, providing a molecular diagnosis and guiding targeted management.

2. Is the home blood draw safe and what preparation is needed?

Answer: Our VIP phlebotomy team uses hospital-grade infection control and cold-chain preservation; no fasting is required, only a filled clinical questionnaire and signed genetic consent.

3. What if the result shows a variant of uncertain significance (VUS)?

Answer: We provide a comprehensive interpretation with familial segregation options and quarterly reanalysis updates; clinical correlation remains essential.

UAE Regulatory & Data Privacy Adherence

Compliance & Accreditation

This service adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Laboratory accredited under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) and DHA/MOHAP standards. All genetic testing requires informed consent and genetic counselling.

Clinical & Logistical Metadata

Test Name GRIN2A Gene Epilepsy with Neurodevelopmental Defects Genetic Test
Price (AED) 2,800 AED
Turnaround Time 3 to 4 weeks
Sample Type / Matrix Peripheral whole blood
Methodology Used Next-Generation Sequencing (NGS) with ACMG variant interpretation
ICD-10-CM Code G40.9, F80.0
LOINC Code 53429-6
DHA Facility License & Laboratory Address License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians